Αρχική World News GLP-1 Receptor Agonist Use Associated with a Significantly Lower Short-Term Incidence of... World News GLP-1 Receptor Agonist Use Associated with a Significantly Lower Short-Term Incidence of Obesity-Associated Cancers Among Obese Individuals Without Diabetes Από Ogkologos - 13 Ιουλίου, 2026 188 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a large real-world cohort Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ EMA recommends granting a marketing authorisation for daraxonrasib Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? MOST POPULAR Identical Twins Find Strength in Shared Breast Cancer Battle After Being... 6 Νοεμβρίου, 2019 A Short-Course of Induction Chemotherapy Followed by Chemoradiotherapy Significantly Improves Survival... 31 Οκτωβρίου, 2024 Two-Time Breast Cancer Warrior Left Devastated After Package Full of Meds... 25 Ιουνίου, 2020 EMA Recommends Granting a Conditional Marketing Authorisation for Selpercatinib 16 Δεκεμβρίου, 2020 Φόρτωση περισσοτέρων HOT NEWS Latest episode of our podcast for cancer researchers Black In Cancer – That Cancer Conversation Targeted Drug Approved for Acute Myeloid Leukemia with IDH1 Gene Mutations Mediterranean Diet Associated with a Higher Probability of Response in Patients...